1. Avinger

    0 Comments Leave a Comment

    1-15 of 86 1 2 3 4 5 6 »

    1. Mentioned In 86 Articles

    2. Avinger Announces First-in-Patient use of Extended Nosecone Version of Next Generation Pantheris

      Explore Avinger Cardiology , Other Business News
      Avinger Announces First-in-Patient use of Extended Nosecone Version of Next Generation Pantheris
      vinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that Arne Schwindt, M.D., a vascular surgeon at St. Franziskus Hospital in Mnster, Germany, successfully treated the first three patients with the extended nosecone version of the next generation Pantheris Lumivascular atherectomy system (A400EX). This product is a line extension of the existing next generation platform, with a longer nosecone that enhances ...
      Read Full Article
      Mentions: Avinger Arne G. Schwindt

    7. Preoperative assessment of computerized tomography angiography to predict success for crossing long Trans-Atlantic Inter-Society Consensus D lesions using the optical coherence tomography catheter

      Explore SAGE Journals Cardiology
      Preoperative assessment of computerized tomography angiography to predict success for crossing long Trans-Atlantic Inter-Society Consensus D lesions using the optical coherence tomography catheter
      ...Objectives Optical coherence tomography chronic total occlusion catheter, the Ocelot (Avinger Inc., Redwood City, CA), has been utilized to cross Trans-Atlantic Inter-Society Consensus D lesions. This study eva...
      Read Full Article
      Mentions: University of Missouri Avinger

    9. Optical coherence tomography for biological imaging

      Explore uspto.gov Patents
      Optical coherence tomography for biological imaging
      Described herein are catheters for use with Optical Coherence Tomography (OCT) that include an optical fiber core having a first refractive index and an interface medium having a second refractive index, where the first and second refractive indexes are mismatched such that receiving electronics configured to receive optical radiation reflected from the reference interface and the target operate in a total noise range that is within 5dB of the shot ...
      Read Full Article
      Mentions: John B. Simpson Avinger

    10. Avinger Announces First Patient Enrolled in its IDE Study of the Pantheris Image-Guided Atherectomy System for Treatment of In-Stent Restenosis

      Explore Optical Coherence Tomography News Cardiology , Other Business News
      Avinger Announces First Patient Enrolled in its IDE Study of the Pantheris Image-Guided Atherectomy System for Treatment of In-Stent Restenosis
      ...s family of atherectomy devices. Avinger is based in Redwood City, CA. For more information, please visit www.avinger.com. Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery D...
      Read Full Article
      Mentions: John B. Simpson Avinger

    11. Avinger Receives CE Marking Approval for In-Stent Restenosis Treatment Indication With Pantheris Image-Guided Atherectomy

      Explore Optical Coherence Tomography News Cardiology , Other Business News
      Avinger Receives CE Marking Approval for In-Stent Restenosis Treatment Indication With Pantheris Image-Guided Atherectomy
      ...s family of atherectomy devices. Avinger is based in Redwood City, CA. For more information, please visit www.avinger.com. Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery D...
      Read Full Article
      Mentions: John B. Simpson Avinger

    14. Lower Extremity Revascularization Using Optical Coherence Tomography–Guided Directional Atherectomy: Final Results of the EValuatIon of the PantheriS OptIcal COherence Tomography ImagiNg Atherectomy System for Use in the Peripheral Vasculature (VISION) St

      Explore SAGE Journals Cardiology
      Lower Extremity Revascularization Using Optical Coherence Tomography–Guided Directional Atherectomy: Final Results of the EValuatIon of the PantheriS OptIcal COherence Tomography ImagiNg Atherectomy System for Use in the Peripheral Vasculature (VISION) St
      Purpose: To evaluate the safety and efficacy of a novel optical coherence tomography (OCT)guided atherectomy catheter in treating patients with symptomatic femoropopliteal disease. Methods: The VISION trial ( ClinicalTrials.gov identifier NCT01937351) was a single-arm, multicenter, global investigational device exemption study enrolling 158 subjects (mean age 67.210.5 years; 87 men) across 20 participating sites. In this cohort, 198 lesions were treated with an average length of 5340 mm ...
      Read Full Article
      Mentions: John B. Simpson Avinger Arne G. Schwindt

    16. Atherectomy catheters devices having multi-channel bushings

      Explore uspto.gov Patents
      Atherectomy catheters devices having multi-channel bushings
      Atherectomy catheters and methods of using them are described herein. In particular, described herein are optical coherence tomography (OCT) catheters that may include a distal tip that can be deflected away from the long axis of the device using a multi-channel bushing. The bushing may include at a hinge point that is offset (e.g., located on a side of the elongate body near the distal end of the elongate ...
      Read Full Article
      Mentions: John B. Simpson Avinger
    17. 1-15 of 86 1 2 3 4 5 6 »
  1. Search:

  2. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology

    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents

    3. Technology:

      Broadband Sources, Probes, Tunable Sources

    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks

  4. About Avinger

    Avinger

    Avinger Inc was founded in 2007 by John B. Simpson, Ph.D., M.D., Avinger, Inc. is developing the next generation of catheter-based technologies for the treatment of cardiovascular and peripheral vascular disease, utilizing our core competencies in medical device catheter engineering and intravascular imaging.  Avinger acquired Sawtooth Laboratories  in 2010.

  5. Related Topics

    1. Optical Coherence Tomography For Biological Imaging
      44 articles also mentioned John B. Simpson
    2. Avinger, Inc. Announces Completion of Merger With Sawtooth Labs, Inc.
      35 articles also mentioned FDA
    3. Avinger to Perform Two Live Ocelot Cases at LINC Conference in Leipzig, Germany
      16 articles also mentioned Arne G. Schwindt
    4. Will 2011 be seen as a “Tipping Point” for Industrial Contribution to the Advancement of the Field of Optical Coherence Tomography?
      8 articles also mentioned St. Jude Medical

  6. Quotes about Avinger

    1. The CE Mark approval for Wildcat is a huge step for Avinger and our dedication to helping the millions of afflicted PAD patients worldwide...With the rate of PAD in Europe closely rivaling the U.S., more and more patients are confronted with the threat of amputation and quality-of-life issues resulting from invasive bypass surgery. We are thrilled to be one step closer to our goal of empowering physicians everywhere with the most advanced tools and technologies to perform the least invasive procedures for PAD sufferers around the globe.
      John B. Simpson in Avinger Receives CE Mark Approval for Its Wildcat Catheter for the Treatment of Peripheral Artery Chronic Total Occlusions and Will Present Results from Its Connect Study at EuroPCR Conference May 17-19
    2. Ocelot CE Mark is a long anticipated milestone for Avinger and a much larger milestone for me professionally. I’ve been working on uniting intravascular guidance with therapeutic products for 30 years and I’m humbled that we’ve been able to achieve this at Avinger... This speaks volumes about our team at Avinger and their dedication to patient care. Ocelot CE Mark is a pivotal step that allows us to immediately help more patients suffering from PAD.”
      John B. Simpson in Avinger Receives CE Mark Approval for Its Ocelot Catheter That Incorporates Real-Time Intravascular Guidance Using Optical Coherence Tomography (OCT)
    3. This is a major milestone for Avinger and a true testament to the perseverance of all our employees and investors. Many people said we couldn't do it...Ocelot and CONNECT II is our first step toward incorporating intravascular imaging into therapeutic catheters. We truly believe this will revolutionize the treatment of vascular disease and amputation prevention.
      John B. Simpson in Avinger Enrolls First European PAD Patient in CONNECT II Global Clinical Trial